Melatonin as an adjuvant treatment modality with doxorubicin
- 1 November 2022
- journal article
- research article
- Published by Elsevier BV in Biochimie
- Vol. 202, 49-55
- https://doi.org/10.1016/j.biochi.2022.06.007
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotesJournal of Pineal Research, 2012
- Melatonin membrane receptors in peripheral tissues: Distribution and functionsMolecular and Cellular Endocrinology, 2012
- Melatonin potentiates chemotherapy‐induced cytotoxicity and apoptosis in rat pancreatic tumor cellsJournal of Pineal Research, 2012
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Melatonin Ameliorates Doxorubicin-induced Skin Necrosis in RatsAnnals of Plastic Surgery, 2010
- Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell linesWorld Journal of Gastroenterology, 2010
- Oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX-4) Combination Chemotherapy as a Salvage Treatment in Advanced Gastric CancerCancer Research and Treatment, 2010
- Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicityBioorganic & Medicinal Chemistry, 2005
- A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancerLung Cancer, 1994
- Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesiusBiotechnology & Bioengineering, 1969